Health and reproductive experiences of women with an FMR1 premutation with and without fragile X premature ovarian insufficiency

Frontiers in Genetics

Volumn 5, Issue AUG, 2014, Pages

  Wheeler, Anne C ^a   Raspa, Melissa ^a   Green, Annette ^a   Bishop, Ellen ^a   Bann, Carla ^a   Edwards, Anne ^a   Bailey Jr , Donald B ^a  

^a RTI INTERNATIONAL   (United States)

Author keywords

FMR1 premutation; Fragile X primary ovarian insufficiency; Women's health

Indexed keywords

FRAGILE X MENTAL RETARDATION PROTEIN; FLUORODEOXYGLUCOSE F 18; IODINE; LUTETIUM 177; TECHNETIUM 99M;

ADULT; ARTICLE; ATAXIA; ATTITUDE TO PREGNANCY; COMORBIDITY; DIZZINESS; FATIGUE; FEMALE; FRAGILE X PRIMARY OVARIAN INSUFFICIENCY; FRAGILE X SYNDROME; FRAGILE X TREMOR ATAXIA SYNDROME; GENE MUTATION; HEALTH SURVEY; HETEROZYGOTE; HUMAN; INFERTILITY THERAPY; MAJOR CLINICAL STUDY; MEDICAL HISTORY; MENTAL DISEASE; MUSCLE WEAKNESS; PAIN; PREGNANCY OUTCOME; PREMATURE OVARIAN FAILURE; QUESTIONNAIRE; REPRODUCTIVE HEALTH; RISK FACTOR; CORONARY ARTERY DISEASE; DIAGNOSTIC ACCURACY; IMAGE RECONSTRUCTION; MYOCARDIAL PERFUSION IMAGING; POSITRON EMISSION TOMOGRAPHY; SCINTIGRAPHY; SENTINEL LYMPH NODE; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

EID: 84906249253     PISSN: None     EISSN: 16648021     Source Type: Journal    
DOI: 10.3389/fgene.2014.00300     Document Type: Article

References (38)

1. Wheeler A, Bailey DB, Berry-Kravis E, Greenberg J, Losh M, Mailick M, Mila M, Olichney J, Rodrigez-Revenga L, Sherman S, Smith L, Summers S, Yang W, Hagerman R. Associated features in females with an FMR1 premutation. J Neurodev Disord 2014, 6:30 DOI: 10.1186/1866-1955-6-30
2. Coffey SM, Cook K, Tartaglia N, Tassone F, Nguyen DV, Pan R, Bronsky HE, Yuhas J, Borodyanskaya M, Grigsby J, Doerflinger M, Hagerman PJ, Hagerman RJ. Expanded clinical phenotype of women with the FMR1 premutation. Am J Med Genet A (2008) 146A(8):1009-16. Epub 2008/03/19. doi: 10.1002/ajmg.a.32060. PubMed PMID: 18348275; PubMed Central PMCID: PMC2888464.
3. Tassone F, Greco CM, Hunsaker MR, Seritan AL, Berman RF, Gane LW, Jacquemont S, Basuta K, Jin LW, Hagerman PJ, Hagerman RJ. Neuropathological, clinical and molecular pathology in female fragile X premutation carriers with and without FXTAS. Genes Brain Behav (2012) 11(5):577-85. Epub 2012/04/03. doi: 10.1111/j.1601-183X.2012.00779.x. PubMed PMID: 22463693; PubMed Central PMCID: PMC3965773.
4. Yang JC, Chan SH, Khan S, Schneider A, Nanakul R, Teichholtz S, Niu YQ, Seritan A, Tassone F, Grigsby J, Hagerman PJ, Hagerman RJ, Olichney JM. Neural substrates of executive dysfunction in fragile X-associated tremor/ataxia syndrome (FXTAS): a brain potential study. Cereb Cortex (2013) 23(11):2657-66. Epub 2012/08/25. doi: 10.1093/cercor/bhs251. PubMed PMID: 22918986; PubMed Central PMCID: PMC3792740.
5. Hashimoto RI, Backer KC, Tassone F, Hagerman RJ, Rivera SM. An fMRI study of the prefrontal activity during the performance of a working memory task in premutation carriers of the fragile X mental retardation 1 gene with and without fragile X-associated tremor/ataxia syndrome (FXTAS). J Psychiatr Res (2011) 45(1):36-43.
6. Hunter JE, Rohr JK, Sherman SL. Co-occurring diagnoses among FMR1 premutation allele carriers. Clin Genet (2010) 77(4):374-81. Epub 2010/01/12. doi: 10.1111/j.1399-0004.2009.01317.x. PubMed PMID: 20059484; PubMed Central PMCID: PMC3696492.
7. Sullivan SD, Welt C, Sherman S. FMR1 and the continuum of primary ovarian insufficiency. Semin Reprod Med (2011) 29(4):299-307. Epub 2011/10/05. doi: 10.1055/s-0031-1280915. PubMed PMID: 21969264.
8. Sherman SL (2000) Premature ovarian failure in the fragile X syndrome. AmJ Med Genet 97,189-194.
9. Murray A. Premature ovarian failure and the FMR1 gene. Semin Reprod Med (2000) 18(1):59-66. Epub 2001/04/13. PubMed PMID: 11299521.
10. Smith LE, Seltzer MM, Greenberg JS. Daily health symptoms of mothers of adolescents and adults with fragile x syndrome and mothers of adolescents and adults with autism spectrum disorder. J Autism Dev Disord (2012) 42(9):1836-46. Epub 2011/12/15. doi: 10.1007/s10803-011-1422-7. PubMed PMID: 22167342; PubMed Central PMCID: PMC3426638.
11. Spath MA, Feuth TB, Allen EG, Smits AP, Yntema HG, van Kessel AG, Braat DD, Sherman SL, Thomas CM. Intra-individual stability over time of standardized anti-Mullerian hormone in FMR1 premutation carriers. Hum Reprod (2011) 26(8):2185-91. Epub 2011/05/18. doi: 10.1093/humrep/der146. PubMed PMID: 21576079; PubMed Central PMCID: PMC3137386.
12. Sullivan AK, Marcus M, Epstein MP, Allen EG, Anido AE, Paquin JJ, Yadav-Shah M, Sherman SL. Association of FMR1 repeat size with ovarian dysfunction. Hum Reprod (2005) 20(2):402-12. Epub 2004/12/21. doi: 10.1093/humrep/deh635. PubMed PMID: 15608041.
13. Hundscheid RD, Braat DD, Kiemeney LA, Smits AP, Thomas CM. Increased serum FSH in female fragile X premutation carriers with either regular menstrual cycles or on oral contraceptives. Hum Reprod (2001) 16(3):457-62. Epub 2001/03/03. PubMed PMID: 11228211.
14. Welt CK. Primary ovarian insufficiency: a more accurate term for premature ovarian failure. Clin Endoc rinol (Oxf) (2008) 68(4):499-509. Epub 2007/11/01. doi: 10.1111/j.1365-x. PubMed PMID: 17970776.
15. Rohr J, Allen EG, Charen K, Giles J, He W, Dominguez C, Sherman SL. Anti-Mullerian hormone indicates early ovarian decline in fragile X mental retardation (FMR1) premutation carriers: a preliminary study. Hum Reprod (2008) 23(5):1220-5. Epub 2008/03/04. doi: 10.1093/humrep/den050. PubMed PMID: 18310677.
16. Allen EG, Sullivan AK, Marcus M, Small C, Dominguez C, Epstein MP, Charen K, He W, Taylor KC, Sherman SL. Examination of reproductive aging milestones among women who carry the FMR1 premutation. Hum Reprod (2007) 22(8):2142-52. Epub 2007/06/26. doi: 10.1093/humrep/dem148. PubMed PMID: 17588953.
17. Mondul AM, Rodriguez C, Jacobs EJ, Calle EE. Age at natural menopause and cause-specific mortality. Am J Epidemiol (2005) 162(11):1089-97. Epub 2005/10/14. doi: 10.1093/aje/kwi324. PubMed PMID: 16221806.
18. Rodriguez-Revenga L, Madrigal I, Alegret M, Santos M, Mila M. Evidence of depressive symptoms in fragile-X syndrome premutated females. Psychiatr Genet (2008) 18(4):153-5. Epub 2008/07/17. doi: 10.1097/YPG.0b013e3282f97e0b. PubMed PMID: 18628675.
19. Ennis S, Ward D, Murray A. Nonlinear association between CGG repeat number and age of menopause in FMR1 premutation carriers. Eur J Hum Genet (2006) 14(2):253-5. Epub 2005/10/28. doi: 10.1038/sj.ejhg.5201510. PubMed PMID: 16251893; PubMed Central PMCID: PMC3725422.
20. Tejada MI, Garcia-Alegria E, Bilbao A, Martinez-Bouzas C, Beristain E, Poch M, Ramos-Arroyo MA, Lopez B, Fernandez Carvajal I, Ribate MP, Ramos F. Analysis of the molecular parameters that could predict the risk of manifesting premature ovarian failure in female premutation carriers of fragile X syndrome. Menopause (2008) 15(5):945-9. Epub 2008/04/23. doi: 10.1097/gme.0b013e3181647762. PubMed PMID: 18427356.
21. Johnston C, Eliez S, Dyer-Friedman J, Hessl D, Glaser B, Blasey C, Taylor A, Reiss A. Neurobehavioral phenotype in carriers of the fragile X premutation. Am J Med Genet (2001) 103(4):314-9. Epub 2001/12/18. PubMed PMID: 11746012.
22. Hunter JE, Leslie M, Novak G, Hamilton D, Shubeck L, Charen K, Abramowitz A, Epstein MP, Lori A, Binder E, Cubells JF, Sherman SL. Depression and anxiety symptoms among women who carry the FMR1 premutation: Impact of raising a child with fragile X syndrome is moderated by CRHR1 polymorphisms. American Journal of Medical Genetics Part B514 Neuropsychiatric Genetics (2012) 159B(5):549-59. doi: 10.1002/Ajmg.B.32061. PubMed PMID: ISI:000304812300009.
23. Roberts JE, Bailey DB, Jr., Mankowski J, Ford A, Sideris J, Weisenfeld LA, Heath TM, Golden RN. Mood and anxiety disorders in females with the FMR1 premutation. Am J Med Genet B Neuropsychiatr Genet (2009) 150B(1):130-9. Epub 2008/06/17. doi: 10.1002/ajmg.b.30786. PubMed PMID: 18553360.
24. Seltzer MM, Barker ET, Greenberg JS, Hong J, Coe C, Almeida D. Differential sensitivity to life stress in FMR1 premutation carrier mothers of children with fragile X syndrome. Health Psychol (2012) 31(5):612-22. Epub 2011/12/14. doi: 10.1037/a0026528. PubMed PMID: 22149120; PubMed Central PMCID: PMC3434309.
25. Kallinen J, Korhonen K, Kortelainen S, Heinonen S, Ryynanen M. Pregnancy outcome in carriers of fragile X. BJOG (2000) 107(8):969-72. Epub 2000/08/24. PubMed PMID: 10955427.
26. Hagerman R, Hagerman P. Advances in clinical and molecular understanding of the FMR1 premutation and fragile X-associated tremor/ataxia syndrome. Lancet Neurol (2013) 12(8):786-98. Epub 2013/07/23. doi: 10.1016/s1474-4422(13)70125-x. PubMed PMID: 23867198; PubMed Central PMCID: PMC3922535.
27. Crum-Bailey JM, Dennison DH, Weiner WJ, Hawley JS. The neurology and corresponding genetics of fragile X disorders: insights into the genetics of neurodegeneration. Future Neurol (2013) 8:225-35.
28. Hunter JE, Allen EG, Abramowitz A, Rusin M, Leslie M, Novak G, Hamilton D, Shubeck L, Charen K, Sherman SL. Investigation of phenotypes associated with mood and anxiety among male and female fragile X premutation carriers. Behav Genet (2008) 38(5):493-502. Epub 2008/06/07. doi: 10.1007/s10519-008-9214-3. PubMed PMID: 18535897; PubMed Central PMCID: PMC3696488.
29. Blackwell DL, Lucas JW, Clarke TC. Summary health statistics for U.S. adults: National Health Interview Survey, 2012. National Center for Health Statistics. Vital Health Stat (2014) 10(260).
30. Mayer EA. The neurobiology of stress and gastrointestinal disease. Gut (2000) 47(6):861-9. Epub 2000/11/15. PubMed PMID: 11076888; PubMed Central PMCID: PMC1728136.
31. Hamlin A, Liu Y, Nguyen DV, Tassone F, Zhang L, Hagerman RJ. Sleep apnea in fragile X premutation carriers with and without FXTAS. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics (2011) 156(8):923-8.
32. Summers SM, Cogswell J, Goodrich JE, Mu Y, Nguyen DV, Brass SD, Hagerman RJ. Fatigue and body mass index in the Fragile X premutation carrier. Fatigue: Biomedicine, Health & Behavior (2014) 2(2):64-72. doi: 10.1080/21641846.2014.881155.
33. Giallo R, Wood CE, Jellett R, Porter R. Fatigue, wellbeing and parental self-efficacy in mothers of children with an autism spectrum disorder. Autism (2013) 17(4):465-80. Epub 2011/07/27. doi: 10.1177/1362361311416830. PubMed PMID: 21788255.
34. Fisher J, Feekery C, Rowe H. Treatment of maternal mood disorder and infant behaviour disturbance in an Australian private mothercraft unit: a follow-up study. Arch Womens Ment Health (2004) 7(1):89-93. Epub 2004/02/14. doi: 10.1007/s00737-003-0041-5. PubMed PMID: 14963738.
35. Ward J, Giallo R. Report on the parent wellbeing and fatigue study. Melbourne: Parenting Research Centre (2008).
36. Ananth CV, Keyes KM, Wapner RJ. Pre-eclampsia rates in the United States, 1980-2010: age-period-cohort analysis. BMJ (2013) 347:f6564. Epub 2013/11/10. doi: 10.1136/bmj.f6564. PubMed PMID: 24201165; PubMed Central PMCID: PMC3898425.
37. Trogstad L, Magnus P, Stoltenberg C. Pre-eclampsia: risk factors and causal models. Best practice & research. Clinical Obstetrics & Gynaecology (2011) 25(3):329-42.
38. Lain KY, Roberts JM. Contemporary concepts of the pathogenesis and management of preeclampsia. JAMA (2002) 287(24):3183-6. Epub 2002/06/22. PubMed PMID: 12076198.